{
    "id": 27238,
    "fullName": "BRCA2 E260Sfs*15",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BRCA2 E260Sfs*15 indicates a shift in the reading frame starting at amino acid 260 and terminating 15 residues downstream causing a premature truncation of the 3418 amino acid Brca2 protein (UniProt.org). Due to the loss of most known functional domains (UniProt.org), E260Sfs*15 is predicted to result in a loss of Brca2 protein function; however, the corresponding cDNA change has been predicted to act as a reversion mutation in the context of a specific inactivating BRCA2 mutation, potentially leading to restoration of the BRCA2 open reading frame and wild-type protein function, as demonstrated by association with acquired resistance to platinum-based chemotherapy and a PARP inhibitor (PMID: 28765325).",
            "references": [
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 675,
        "geneSymbol": "BRCA2",
        "terms": [
            "BRCA2",
            "BRCC2",
            "BROVCA2",
            "FACD",
            "FAD",
            "FAD1",
            "FANCD",
            "FANCD1",
            "GLM3",
            "PNCA2",
            "XRCC11"
        ]
    },
    "variant": "E260Sfs*15",
    "createDate": "11/13/2017",
    "updateDate": "06/24/2018",
    "referenceTranscriptCoordinates": {
        "id": 168735,
        "transcript": "NM_000059",
        "gDna": "chr13:g.32331015_32331016delGA",
        "cDna": "c.778_779delGA",
        "protein": "p.E260Sfs*15",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13100,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a breast cancer patient harboring BRCA2 D252Vfs*24 progressed while being treated with Carboplatin and a PARP inhibitor, and via cell-free DNA testing was found to have acquired nine somatic reversion mutations, BRCA2 D244Efs*10, BRCA2 D244Rfs*7, BRCA2 E260Sfs*15, BRCA2 I247_E254del, BRCA2 I247Yfs*8, BRCA2 N255Tfs*21, BRCA2 N257Efs*19, BRCA2 R245_D252del, BRCA2 T256Kfs*19, which restored the open reading frame, resulting in wild-type BRCA2 protein function (PMID: 28765325).",
            "molecularProfile": {
                "id": 29010,
                "profileName": "BRCA2 D244Efs*10 BRCA2 D244Rfs*7 BRCA2 R245_D252del BRCA2 I247_E254del BRCA2 I247Yfs*8 BRCA2 D252Vfs*24 BRCA2 N255Tfs*21 BRCA2 T256Kfs*19 BRCA2 N257Efs*19 BRCA2 E260Sfs*15"
            },
            "therapy": {
                "id": 6753,
                "therapyName": "Carboplatin + Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 10297,
                    "pubMedId": 28765325,
                    "title": "Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28765325"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28656,
            "profileName": "BRCA2 E260Sfs*15",
            "profileTreatmentApproaches": [
                {
                    "id": 16961,
                    "name": "PARP-1 Inhibitor",
                    "profileName": "BRCA2 E260Sfs*15"
                },
                {
                    "id": 16960,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "BRCA2 E260Sfs*15"
                }
            ]
        },
        {
            "id": 29010,
            "profileName": "BRCA2 D244Efs*10 BRCA2 D244Rfs*7 BRCA2 R245_D252del BRCA2 I247_E254del BRCA2 I247Yfs*8 BRCA2 D252Vfs*24 BRCA2 N255Tfs*21 BRCA2 T256Kfs*19 BRCA2 N257Efs*19 BRCA2 E260Sfs*15",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 168735,
            "transcript": "NM_000059",
            "gDna": "chr13:g.32331015_32331016delGA",
            "cDna": "c.778_779delGA",
            "protein": "p.E260Sfs*15",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}